Monitor the ADS bid price for any sustained recovery above $1.00. The reverse stock split authorization provides a clear path to compliance, but its implementation would signal ongoing price weakness. Watch for any Nasdaq Staff discretion to extend the compliance period if the company makes progress.
Price Chart
Executive Summary
Genenta Science received a Nasdaq minimum bid price deficiency notice on October 16, 2026, as its ADSs closed below $1.00 for 30 consecutive business days. The company has until April 14, 2027, to regain compliance, with a shareholder-approved reverse stock split (1:10 to 1:20) available as a potential cure. The notification has no immediate effect on trading, but the stock faces delisting risk if compliance is not achieved.
Key Facts
- Nasdaq notified Genenta on October 16, 2026, of non-compliance with the $1.00 minimum bid price rule (Rule 5550(a)(2)).
- The bid price was below $1.00 for 30 consecutive business days from September 3, 2026, through October 15, 2026.
- The company has a 180-day initial compliance period ending April 14, 2027.
- Shareholders approved a reverse stock split at a ratio of 1-for-10 to 1-for-20 at the July 29, 2026 Extraordinary Shareholders' Meeting.
- The company may be eligible for an additional 180-day compliance period if it meets other listing standards and provides notice of intent to cure.
Financial Impact
No financial figures provided; delisting risk is the primary concern.
Risk Factors
- Failure to regain compliance by April 14, 2027, could lead to delisting from Nasdaq.
- A reverse stock split, if implemented, may not attract sufficient buying interest to maintain the bid price above $1.00.
- The company may not qualify for an additional 180-day compliance period if it fails to meet other listing standards.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-047888 |
| Exhibit: ex99-1.htm | 0001493152-26-047888 |
| Document: 0001493152-26-047888-index-headers.html | 0001493152-26-047888 |
| Document: 0001493152-26-047888-index.html | 0001493152-26-047888 |
| Document: 0001493152-26-047888.txt | 0001493152-26-047888 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | 6-K | $0.6300 | awaiting T+60 | — | $0.6182 (−1.87%) |
Oct 21, 2026 6d ago | 6-K | $0.6301 | awaiting T+60 | — | $0.6182 (+1.89%) |
Oct 21, 2026 6d ago | Press Release | $0.6301 | awaiting T+60 | — | $0.6182 (+1.89%) |
Oct 13, 2026 14d ago | 6-K | $0.6602 | awaiting T+60 | — | $0.6182 (+6.36%) |
Oct 7, 2026 20d ago | 6-K | $0.7101 | awaiting T+60 | — | $0.6182 (−12.94%) |
Oct 2, 2026 25d ago | SC 13D/A | $0.7450 | awaiting T+60 | — | $0.6182 (−17.02%) |
Jul 22, 2026 13w ago | Press Release | $1.64 $0.6694 | ▼ −59.18% | ▼ −62.44% | $0.6182 (−62.30%) |
Jun 26, 2026 17w ago | 6-K | $1.80 $0.7040 | ▼ −60.89% | ▼ −65.27% | $0.6182 (−65.66%) |
Jun 17, 2026 18w ago | 6-K | $1.84 $0.8408 | ▼ −54.30% | ▼ −57.45% | $0.6182 (−66.40%) |
Jun 16, 2026 19w ago | 6-K | $1.87 $0.8613 | ▼ −53.94% | ▼ −54.94% | $0.6182 (−66.94%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers